Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 Mar;53(3):182–185. doi: 10.1136/thx.53.3.182

Non-tuberculous mycobacteria in cystic fibrosis

J Torrens 1, P Dawkins 1, S Conway 1, E Moya 1
PMCID: PMC1745162  PMID: 9659352

Abstract

BACKGROUND—The clinical significance of the presence of non-tuberculous mycobacteria in the sputum of patients with cystic fibrosis is unclear. A retrospective case-control study was performed to assess possible risk factors for non-tuberculous mycobacteria and its impact on clinical status in patients with cystic fibrosis.
METHODS—The records of all patients attending the Leeds cystic fibrosis clinics who were positive for non-tuberculous mycobacteria were examined. Each case was matched with two controls for sex, age, and respiratory function at the time of the first non-tuberculous mycobacteria isolate. Details of respiratory function, nutritional status, antibiotic and corticosteroid therapy, Shwachman-Kulczycki (S-K) score, Northern chest radiographic score, and the frequency of isolation of other bacteria and fungi were collected from two years before to two years after the first non-tuberculous mycobacteria isolate. The patients' genotype and the presence of diabetes mellitus were also recorded.
RESULTS—Non-tuberculous mycobacteria were isolated from 14 patients out of a cystic fibrosis population of 372 (prevalence = 3.8%). No significant effect of non-tuberculous mycobacteria was seen on respiratory function, nutritional status, or S-K score. There was a significant association with the number of intravenous antibiotic courses received before the first isolate with cases receiving, on average, twice as many courses as controls (cases 6.64, controls 2.86, 95% CI for difference 1.7 to 5.9). No significant difference was seen between cases and controls for Northern scores, previous steroid therapy, or the incidence of diabetes mellitus.
CONCLUSIONS—Non-tuberculous mycobacteria infection in patients with cystic fibrosis is uncommon and its clinical impact appears to be minimal over a two year period. Frequent intravenous antibiotic usage is a possible risk factor for colonisation with non-tuberculous mycobacteria.



Full Text

The Full Text of this article is available as a PDF (88.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken M. L., Burke W., McDonald G., Wallis C., Ramsey B., Nolan C. Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest. 1993 Apr;103(4):1096–1099. doi: 10.1378/chest.103.4.1096. [DOI] [PubMed] [Google Scholar]
  2. Boxerbaum B. Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. J Pediatr. 1980 Apr;96(4):689–691. doi: 10.1016/s0022-3476(80)80743-8. [DOI] [PubMed] [Google Scholar]
  3. Conway S. P., Pond M. N., Bowler I., Smith D. L., Simmonds E. J., Joanes D. N., Hambleton G., Hiller E. J., Stableforth D. E., Weller P. The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores. Thorax. 1994 Sep;49(9):860–862. doi: 10.1136/thx.49.9.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis. 1990 Oct;142(4):940–953. doi: 10.1164/ajrccm/142.4.940. [DOI] [PubMed] [Google Scholar]
  5. Efthimiou J., Smith M. J., Hodson M. E., Batten J. C. Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis. Br J Dis Chest. 1984 Jul;78(3):299–302. [PubMed] [Google Scholar]
  6. Fauroux B., Delaisi B., Clément A., Saizou C., Moissenet D., Truffot-Pernot C., Tournier G., Vu Thien H. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J. 1997 Apr;16(4):354–358. doi: 10.1097/00006454-199704000-00004. [DOI] [PubMed] [Google Scholar]
  7. Gilligan P. H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev. 1991 Jan;4(1):35–51. doi: 10.1128/cmr.4.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heurlin N., Petrini B. Treatment of non-tuberculous mycobacterial infections in patients without AIDS. Scand J Infect Dis. 1993;25(5):619–623. doi: 10.3109/00365549309008551. [DOI] [PubMed] [Google Scholar]
  9. Hjelt K., Højlyng N., Howitz P., Illum N., Munk E., Valerius N. H., Fursted K., Hansen K. N., Heltberg I., Koch C. The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis. Scand J Infect Dis. 1994;26(5):569–576. doi: 10.3109/00365549409011815. [DOI] [PubMed] [Google Scholar]
  10. Hjelte L., Petrini B., Källenius G., Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax. 1990 May;45(5):397–400. doi: 10.1136/thx.45.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kilby J. M., Gilligan P. H., Yankaskas J. R., Highsmith W. E., Jr, Edwards L. J., Knowles M. R. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest. 1992 Jul;102(1):70–75. doi: 10.1378/chest.102.1.70. [DOI] [PubMed] [Google Scholar]
  12. Kinney J. S., Little B. J., Yolken R. H., Rosenstein B. J. Mycobacterium avium complex in a patient with cystic fibrosis: disease vs. colonization. Pediatr Infect Dis J. 1989 Jun;8(6):393–396. doi: 10.1097/00006454-198906000-00013. [DOI] [PubMed] [Google Scholar]
  13. Lamden K., Watson J. M., Knerer G., Ryan M. J., Jenkins P. A. Opportunist mycobacteria in England and Wales: 1982 to 1994. Commun Dis Rep CDR Rev. 1996 Oct 11;6(11):R147–R151. [PubMed] [Google Scholar]
  14. Mulherin D., Coffey M. J., Halloran D. O., Keogan M. T., FitzGerald M. X. Skin reactivity to atypical mycobacteria in cystic fibrosis. Respir Med. 1990 Jul;84(4):273–276. doi: 10.1016/s0954-6111(08)80052-2. [DOI] [PubMed] [Google Scholar]
  15. Pike M. C., Morrow R. H. Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med. 1970 Feb;24(1):42–44. doi: 10.1136/jech.24.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SHWACHMAN H., KULCZYCKI L. L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. doi: 10.1001/archpedi.1958.02060060008002. [DOI] [PubMed] [Google Scholar]
  17. Smith M. J., Efthimiou J., Hodson M. E., Batten J. C. Mycobacterial isolations in young adults with cystic fibrosis. Thorax. 1984 May;39(5):369–375. doi: 10.1136/thx.39.5.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tomashefski J. F., Jr, Stern R. C., Demko C. A., Doershuk C. F. Nontuberculous mycobacteria in cystic fibrosis. An autopsy study. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):523–528. doi: 10.1164/ajrccm.154.2.8756832. [DOI] [PubMed] [Google Scholar]
  19. Wheeler P. W., Lancaster D., Kaiser A. B. Bronchopulmonary cross-colonization and infection related to mycobacterial contamination of suction valves of bronchoscopes. J Infect Dis. 1989 May;159(5):954–958. doi: 10.1093/infdis/159.5.954. [DOI] [PubMed] [Google Scholar]
  20. Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis. 1992 Jul;15(1):1–10. doi: 10.1093/clinids/15.1.1. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES